Literature DB >> 8460194

Construction of the fixed part of the neourethra in female-to-male transsexuals: experience in 53 patients.

J J Hage1, F G Bouman, J J Bloem.   

Abstract

Genital construction in female-to-male transsexuals should ideally involve the creation of a competent neourethra, allowing the patients to void while standing. A short review of the literature on this subject is given. In our hospital, construction of the fixed part of the urethra up to the level of the clitoris has been accomplished using an anterior vaginal flap as described by Thompson and by Bouman in 46 subjects. Initially, serious complications such as vesicovaginal and urethrovaginal fistulas and urinary incontinence were encountered in this series. Subsequently, in experienced hands, this seems to be a technique with few risks. Formation of a urethrocutaneous fistula at the level of the female external urethral orifice can be successfully prevented using this flap. The problem of neourethral urine residue has still to be solved.

Entities:  

Mesh:

Year:  1993        PMID: 8460194

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN: 0032-1052            Impact factor:   4.730


  4 in total

Review 1.  An overview of female-to-male gender-confirming surgery.

Authors:  Shane D Morrison; Mang L Chen; Curtis N Crane
Journal:  Nat Rev Urol       Date:  2017-05-16       Impact factor: 14.432

2.  [Modern concept for treatment of the female-to-male transsexual].

Authors:  J Dabernig; O Schumacher; C Lenz; R Rickard; A Turner; W Dabernig; J Schaff
Journal:  Urologe A       Date:  2007-06       Impact factor: 0.639

Review 3.  Reconstructive Management Pearls for the Transgender Patient.

Authors:  Geolani W Dy; Jeff Sun; Michael A Granieri; Lee C Zhao
Journal:  Curr Urol Rep       Date:  2018-04-11       Impact factor: 3.092

Review 4.  Total phallic construction techniques in transgender men: an updated narrative review.

Authors:  Marco Falcone; Mirko Preto; Gideon Blecher; Massimiliano Timpano; Paolo Gontero
Journal:  Transl Androl Urol       Date:  2021-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.